ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc (CYCN)

2.99
0.08
(2.75%)
Cerrado 17 Enero 3:00PM
2.99
0.00
( 0.00% )
Pre Mercado: 6:03AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
2.99
Postura de Compra
2.99
Postura de Venta
3.39
Volume Operado de la Acción
10
0.00 Rango del Día 0.00
1.27 Rango de 52 semanas 9.4699
Capitalización de Mercado [m]
Precio Anterior
2.99
Precio de Apertura
-
Hora
2
@
3
Última hora de negociación
06:24:46
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
3,525,242
Acciones en circulación
2,710,096
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.54
Beneficio por acción (BPA)
-1.94
turnover
-
Beneficio neto
-5.26M

Acerca de Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of nex... Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Boston, Massachusetts, USA
Fundado
-
Cyclerion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CYCN. The last closing price for Cyclerion Therapeutics was US$2.99. Over the last year, Cyclerion Therapeutics shares have traded in a share price range of US$ 1.27 to US$ 9.4699.

Cyclerion Therapeutics currently has 2,710,096 shares in issue. The market capitalisation of Cyclerion Therapeutics is US$8.10 million. Cyclerion Therapeutics has a price to earnings ratio (PE ratio) of -1.54.

CYCN Últimas noticias

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company’s next stage of growth. The...

Regina Graul, Ph.D., Promoted to Chief Executive Officer

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D., has been promoted to Chief Executive Officer...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.3-9.118541033433.293.32822.8889252.93203273CS
4-0.13-4.166666666673.123.66712.8706683.15356281CS
12-0.19-5.97484276733.189.46991.2735252425.28898037CS
26-0.53-15.05681818183.529.46991.2715545925.28346817CS
52-0.5-14.32664756453.499.46991.277791845.27777801CS
156-21.21-87.644628099224.229.81.273562267.38663766CS
260-62.01-95.465179.21.2743718741.78593937CS

CYCN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cyclerion Therapeutics?
El precio actual de las acciones de Cyclerion Therapeutics es US$ 2.99
¿Cuántas acciones de Cyclerion Therapeutics están en circulación?
Cyclerion Therapeutics tiene 2,710,096 acciones en circulación
¿Cuál es la capitalización de mercado de Cyclerion Therapeutics?
La capitalización de mercado de Cyclerion Therapeutics es USD 8.1M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cyclerion Therapeutics?
Cyclerion Therapeutics ha negociado en un rango de US$ 1.27 a US$ 9.4699 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cyclerion Therapeutics?
El ratio precio/beneficio de Cyclerion Therapeutics es -1.54
¿Cuál es la moneda de reporte de Cyclerion Therapeutics?
Cyclerion Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Cyclerion Therapeutics?
El último beneficio anual de Cyclerion Therapeutics es USD -5.26M
¿Cuál es la dirección registrada de Cyclerion Therapeutics?
La dirección registrada de Cyclerion Therapeutics es 155 FEDERAL STREET, SUITE 700, BOSTON, MASSACHUSETTS, 02110
¿Cuál es la dirección del sitio web de Cyclerion Therapeutics?
La dirección del sitio web de Cyclerion Therapeutics es www.cyclerion.com
¿En qué sector industrial opera Cyclerion Therapeutics?
Cyclerion Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ASSTAsset Entities Inc
US$ 1.21
(160.50%)
76.36M
HSDTHelius Medical Technologies Inc
US$ 1.2495
(66.38%)
46.22M
BBGIBeasley Broadcast Group Inc
US$ 13.17
(59.25%)
24
EDRYEuroDry Ltd
US$ 18.08
(58.88%)
12
LXEOLexeo Therapeutics Inc
US$ 7.99
(57.59%)
13
GOEVCanoo Inc
US$ 0.3925
(-70.93%)
3.87M
ELVNEnliven Therapeutics Inc
US$ 10.11
(-52.91%)
20
CUBLionheart Holdings
US$ 5.11
(-49.51%)
2
ALRSAlerus Financial Corporation
US$ 12.01
(-38.79%)
13
MDXGMiMedx Group Inc
US$ 6.01
(-34.10%)
10
CRKNCrown Electrokinetics Corporation
US$ 0.136
(8.80%)
112.16M
GCTKGlucoTrack Inc
US$ 0.106
(24.85%)
99.29M
ASSTAsset Entities Inc
US$ 1.21
(160.50%)
76.33M
HSDTHelius Medical Technologies Inc
US$ 1.2495
(66.38%)
46.22M
NIVFNewGenIvf Group Ltd
US$ 0.3173
(-9.08%)
25.9M

CYCN Discussion

Ver más
georgie18 georgie18 2 semanas hace
CYCN...$3.24...🥳... https://schrts.co/BZqjIquT ...Float in 2 Million range...CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company’s next stage of growth. The Company is leveraging its legacy soluble guanylate cyclase (sGC) stimulator assets to generate near-term revenues which will be used to implement its strategic building plan without near-term dilution.

“These agreements demonstrate Cyclerion’s progress in maximizing its legacy asset value while redirecting resources toward acquiring potential new assets,” said Regina Graul, Ph.D., President and Chief Executive Officer of Cyclerion. “These newly finalized agreements, combined with our significant reduction of operating expenses, enable the focused use of our capital to support our anticipated pipeline build in the central nervous system (CNS) space. Concurrently, we plan to raise capital, as needed, to fund our product plans to create value for shareholders and patients.” Graul continued, “Cyclerion’s diligence team, comprised of committed external experts in their respective fields, is currently in advanced stages of conducting promising asset evaluations, which we believe have the potential to be the new foundation for Cyclerion.”

Cyclerion and Akebia have re-negotiated a mutually beneficial amendment to their exclusive license agreement for praliciguat, a systemic sGC stimulator. Under the new license amendment with Akebia, Cyclerion will receive $1.75 million in upfront and near-term payments. In addition, Akebia will assume responsibility for all intellectual property expenses associated with praliciguat after Q1 2025. In 2021, Akebia paid a $3.0 million upfront payment to the Company upon signing of the license agreement, and the Company is eligible to receive additional milestone cash payments of up to approximately $560 million in total potential future development, regulatory, and commercialization milestone payments for praliciguat. In exchange for a reduction in certain development milestone payments, Cyclerion is eligible to receive certain higher, tiered, sales-based royalties ranging from mid-single-digits to twenty percent.

Cyclerion has also entered into an exclusive license option agreement for its vascular sGC stimulator, olinciguat, with a separate entity, wholly controlled by CVCO Therapeutics, Inc., a clinical stage company focused on microvascular dysfunction in cardiovascular, inflammatory and metabolic disease states. Under the terms of the agreement, the potential partner has exclusive rights to evaluate olinciguat during the option period. During the option period, the grantee has assumed responsibility for all ongoing intellectual property-related expenses associated with olinciguat.

As part of its strategic initiatives, Cyclerion previously announced a definitive agreement for the sale of its CNS assets zagociguat and CY3018 to Tisento Therapeutics in May 2023 for an $8 million cash payment and a 10% equity stake in Tisento. The amended agreement for praliciguat, and if the option for olinciguat is exercised, would represent the likely final steps in the monetization of Cyclerion’s historical portfolio. Cyclerion believes it is well positioned for the next phase in its overall strategy, to bring in new CNS assets to rebuild the pipeline.
👍️0
LowFloatLopes LowFloatLopes 2 meses hace
That's usually exactly what I do sometimes I'll gamble though and stay in longer like I did today :) good strategy 👍🏼
👍️ 1
Strukture Strukture 2 meses hace
I just sell the top of the rips buy the dips so long as the trend stays bullish if it goes para after i sell thats ok too
👍️0
LowFloatLopes LowFloatLopes 2 meses hace
Right on cue lol 
👍️0
LowFloatLopes LowFloatLopes 2 meses hace
IM still holding from that past.. I'm feeling a pop 29 or 10 in the next hour
👍️0
trader59 trader59 2 meses hace
Automated wash trading, brazen manipulation of the PPS. The O/S is 2.7M shares, which means that each and every share issued and outstanding has changed hands, on average, over 40 times today. Once they turn their computers off, folks will be trapped with grossly overpriced bags.
👍️0
Strukture Strukture 2 meses hace
I was out at 8.20 on that push for a quick 30%
👍️0
tw0122 tw0122 2 meses hace
Gave you green light alert at $4s premarket ..lol on the monthly chart all green with 3 hits the 3rd being today 
👍️0
PonkenPlonken PonkenPlonken 2 meses hace
mhmm
👍️0
LowFloatLopes LowFloatLopes 2 meses hace
Got a sale set at 9.70
👍️0
LowFloatLopes LowFloatLopes 2 meses hace
6.45 here :)
👍️0
Strukture Strukture 2 meses hace
Re loaded at 6.30 halted up back at HOD 8.40
👍️0
ecmoney ecmoney 2 meses hace
Halted again $8.39

Ec
👍️0
LowFloatLopes LowFloatLopes 2 meses hace
In at $4.30 out at $7.90 in 15 mins lol 
👍️0
Strukture Strukture 2 meses hace
CYCN Boom
👍️0
ecmoney ecmoney 2 meses hace
Halted at $6

Rc
👍️0
Invest-in-America Invest-in-America 2 meses hace
CYCN: Could NOT find any PR's nor otherwise NEWS anywhere to support this??? (Just the MM machines & algos???)
👍️0
ecmoney ecmoney 2 meses hace
Thinking about jumping back in around $5


Ec
👍️0
glenn1919 glenn1919 2 meses hace
CYCN.....................................$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
👍️0
ecmoney ecmoney 2 meses hace
I’m out

Easy 300%

Ec
👍️0
tw0122 tw0122 2 meses hace
$6.43 + 300% going to cash out now 
👍️0
tw0122 tw0122 2 meses hace
$5.49'+ 250%
👍️0
tw0122 tw0122 2 meses hace
Party over here also $5.05 + 210%
👍️0
tw0122 tw0122 2 meses hace
CYCN $4.88 + 200% 
👍️0
tw0122 tw0122 2 meses hace
CYCN 2.62 +92% flip out time 
👍️0
glenn1919 glenn1919 2 meses hace
cycn.......................................................https://stockcharts.com/h-sc/ui?s=cycn&p=D&yr=0&mn=2&dy=12&id=p84071410134


...............................nice bounce & volume..................................................
👍️0
tw0122 tw0122 2 meses hace
2.49 +'83%
👍️0
tw0122 tw0122 2 meses hace
CYCN $2.26 + 70%
👍️0
glenn1919 glenn1919 2 meses hace
CYCN.................................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 meses hace
CYCN.................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 2 meses hace
$2.40- $2.65 first line of resistance breaks solid $3.16 next 
👍️0
tw0122 tw0122 2 meses hace
Mini pump
👍️0
Banjo50 Banjo50 6 meses hace
It should be five cents. I bid five cents.
👍️0
Invest-in-America Invest-in-America 6 meses hace
CYCN: Closed up by 55% today (Etrade), but no posts here for months.
👍️0
dinogreeves dinogreeves 2 años hace
CYCN with big volume could run to the teens.
👍️0
dinogreeves dinogreeves 2 años hace
Boombaska.
👍️0
dinogreeves dinogreeves 2 años hace
One heck of a run coming here fairly soon. Buy the dip and enjoy the rip. CEO paid $8.50 for shares here.
👍️0
Invest-in-America Invest-in-America 2 años hace
CYCN: Hey, & "Little Debbie" is still alive and well!! (See her below!! However, NOT quite as 'cute' as she used to be, though.)



👍️0
subslover subslover 2 años hace
LMAO. You're still partying from Friday night. I know a few peps that need your stuff! :)
👍️0
Invest-in-America Invest-in-America 2 años hace
CYCN: Get ready to PARTY!!! My glorious CYCN HomeBoys, HomeGirls, & straight-up GangBangers!!! I gots the party MUSIC for ya-all, below!!! Who's gonna bring the REFRESHMENTS!!!??? (Hey, Admiral S-L, how about some disruptive, brand-new, very tasty, "Little-Debbie-Cannabis-Infused-Strawberry-Snack-Cakes", Dude!!!???)

👍️0
subslover subslover 2 años hace
Cyclerion's zagociguat gets FDA orphan drug status
👍️0
subslover subslover 2 años hace
Cyclerion's zagociguat gets FDA orphan drug status
👍️0
NYCJR NYCJR 2 años hace
funny its a lot more than that now , close to 12x your call, lol
👍️0
willlbone willlbone 2 años hace
45% layoffs. Bid 25 cents.
👍️0
Banjo50 Banjo50 2 años hace
I think it should be 5 cents. I bid 5 cents EACH for 100 shares. Five cents is fair.
👍️0
kzivann kzivann 2 años hace
Bid for some.

CYCN
👍️0
willlbone willlbone 3 años hace
Bounce back and close the gap.
👍️0
Banjo50 Banjo50 3 años hace
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
Banjo50 Banjo50 3 años hace
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
ClayTrader ClayTrader 4 años hace
* * $CYCN Video Chart 06-08-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

Su Consulta Reciente

Delayed Upgrade Clock